AGTR1 and Parkinson disease: In humans, recent studies revealed that high AT1 receptor gene (AGTR1) expression identifies the most vulnerable human dopaminergic neurons [6,7,8] and that treatment with AT1 blockers decreases the risk of PD development [9,10,11].